“showed a trend”

The Shannon diversity index showed a trend towards an increased bacterial diversity in the non-secretor individuals (p = 0.07).

The increment in the prevalence of overweight were not significant in women; however, results showed a trend ( P = 0.07).

This is consistent with a reported reduction in reversal frequency following starvation [38] and we also found that food-deprived worms showed a trend towards a reduction in reversal compared to well-fed worms in the food race ( Figure 6D ; p = 0.07).

Patients without lymph node involvement (pN0) showed a trend toward longer overall survival (pN0: not achieved, pN+: 22.5 months, P = 0.07).

In these subjects the associations between ppRV and these SNPs showed a trend toward significance only for S1 (mean ppRV = 132.1 for the common genotype, n = 379, and ppRV = 118.4 for the less common genotypes, n = 74, p value < 0.07).

In our sample, depressed individuals reported greater trauma exposure than controls ( p < 0.001), and although CTQ binary exposure only showed a trend toward association with brain-PAD ( p = 0.07), this pattern aligns with previous findings linking greater adversity to advanced brain-PADs (Hatton et al., 2018 ).

conducted a multicenter retrospective study of 130 newly diagnosed older AML patients receiving HMA/venetoclax and found that while pre-existing CKD showed a trend toward lower overall response rates (OR: 0.5; p=0.07), it did not significantly affect overall survival; however, acute kidney injury during treatment was an independent prognostic factor for inferior overall survival (HR: 1.86; p=0.01) [ 15 ].

Ischemic heart disease and dementia also showed a trend toward predicted the ED delirium (OR, 2.20; 95% CI, 0.93–5.20; P = 0.07 and OR, 5.54; 95% CI, 0.91–33.53; P = 0.06, respectively). 4.

STZ administration showed a trend toward reduced mature BDNF content compared with the SHAM group ( p = 0.07), whereas combined VitD 3 and DMF treatment significantly increased mature BDNF content compared with the STZ group.

Patients who developed thyroid irAEs showed a trend toward improved OS (log-rank p = 0.07; HR 0.45, 95% CI 0.19–1.08), which reached statistical significance after adjustment for predefined confounders (HR 0.40, 95% CI 0.17–0.98; p = 0.045).

Grafts with a GRWR < 0.8 showed a trend toward higher proportional growth (137% ± 55% vs. 110% ± 41%; p = 0.07 for parametric, p = 0.04 for non-parametric).

The corresponding unadjusted and age-adjusted estimates showed a trend toward more abnormal sleep timing among those with prior normotensive pregnancy (both P ≈.07).

When stratified by sex, this study showed a trend toward higher sarcopenia prevalence in women with elevated TFAM levels, albeit this did not reach statistical significance ( p = 0.07).

These post-hoc comparisons also showed a trend that Remember trials were associated with increased frequency of subsequent information-seeking relative to Unfamiliar trials, p = 0.07.

The primary diagnosis of neurological conditions showed a trend toward increased odds of moderate (OR: 16.27; 95% CI: 0.82–322.65; p = 0.07) and high stress (OR: 6.86; 95% CI: 0.14–343.83; p = 0.34) compared to cardiovascular admissions, but these associations did not reach statistical significance.

A Kaplan–Meier survival analysis showed a trend toward poor OS (3-year OS of 65% vs. 74%, p = 0.07) and significantly poor EFS overall (3-year EFS of 43% vs. 54%, p = 0.03) in low-FOXO3 expressers compared to patients with a high FOXO3 expression ( Figure 4 B).

ANRIL Gene Polymorphisms The estimated haplotype T A A A (corresponding to SNPs rs1333045, rs1333048, rs4977574, and rs10757278) showed a trend toward higher prevalence in autism cases compared to controls (OR (95% CI) = 1.77 (1.19–2.64), adjusted P = 0.07).

Clinical nodal stage showed a trend: cN2 disease accounted for 63% of complex cases compared with 25% of cN1 and 39% of cN0 ( P = .07).

Survival showed a trend to correlate with log titre F IgG (Supplemental Figure S2A, p = 0.07), but not with the log titre G pvNAb (Supplemental Figure S2B, p = 0.38).

Compared to patients on MT, those undergoing CA showed a trend towards a reduction in the composite endpoint (RR 0.59; (95% CI: 0.33–1.05); p = 0.07; I 2 = 17%) ( Figure 6 c) and a significative reduction in HF hospitalizations (RR 0.57; (95% CI: 0.41–0.78); p = 0.0006; I 2 = 0%) and AF recurrence (RR 0.35; (95% CI: 0.22–0.55); p < 0.00001; I 2 = 82%).

Patients with UC showed a trend to an increased ARFID risk, without reaching significant differences with CD (62.5% UC vs 37.5% CD; P = .07).

Results: HIIE and MICE showed a trend to decrease ghrelin levels immediately post-exercise (-14.1 ± 21.6% and −9.6 ± 23.8%, respectively, p = 0.07) and decreased 1h post-exercise (-12.7 ± 31.8% and −13.8 ± 21.7%, respectively, p < 0.05).

OS also showed a trend that favored BsAb exposure in the IPTW-adjusted model ( P = .07) but remained comparable across groups in the matched and unadjusted analyses.

No significant sex interactions were observed, although state 8 showed a trend ( p = .07).

Our results showed a trend towards more frequent adequate mucosal visibility with 1 L PEG-ASC compared to 2 L PEG (small bowel mucosal visibility ≥2 in all three small bowel tertiles, p =0.07), as per the SBMVSS score.